Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

What Are the Best Sports for Weight Loss? Losing weight doesn’t have to be all about sweaty gyms or expensive personal ...